Thapsigargin and its prodrug derivatives: exploring novel approaches for targeted cancer therapy through calcium signaling disruption.

Saved in:
Bibliographic Details
Title: Thapsigargin and its prodrug derivatives: exploring novel approaches for targeted cancer therapy through calcium signaling disruption.
Authors: Khurram I; Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.; Centre for Applied Molecular Biology, University of the Punjab, Lahore, Pakistan., Khan MU; Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan. muhammad.umer4@mlt.uol.edu.pk., Ibrahim S; Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.; Centre for Applied Molecular Biology, University of the Punjab, Lahore, Pakistan., Ghani MU; Centre for Applied Molecular Biology, University of the Punjab, Lahore, Pakistan., Amin I; Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan., Falzone L; Department of Biomedical and Biotechnological Sciences, University of Catania, 95123, Catania, Italy., Herrera-Bravo J; Departamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomas, Santiago, Chile. jesusherrerabr@santotomas.cl., Setzer WN; Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT, 84043, USA.; Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL, 35899, USA., Sharifi-Rad J; Universidad Espíritu Santo, Samborondón, Ecuador. javad.sharifirad@gmail.com.; Centro de Estudios Tecnológicos y, Universitarios del Golfo, Veracruz, Mexico. javad.sharifirad@gmail.com.; Department of Medicine, College of Medicine, Korea University, Seoul, 02841, Republic of Korea. javad.sharifirad@gmail.com., Calina D; Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania. calinadaniela@gmail.com.
Source: Medical oncology (Northwood, London, England) [Med Oncol] 2024 Nov 19; Vol. 42 (1), pp. 7. Date of Electronic Publication: 2024 Nov 19.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1559-131X
DOI:10.1007/s12032-024-02541-z